EUVIMEDEUVIMED entdecken
Crossref

Antiviral signaling of a type III CRISPR-associated deaminase

Yutao Li iD, Zhaoxing Li iD, Purui Yan iD, Chenyang Hua iD, Jianping Kong iD, Wanqian Wu, Yurong Cui, Yan Duan, Shunxiang Li iD, Guanglei Li, Shunli Ji iD, Yijun Chen iD und 6 weitere

Science · 2025

DOI: 10.1126/science.adr0393 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, 2025. Verfasst von Yutao Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China. Hauptthemen laut MEDLINE: Adenosine Deaminase, Adenosine Triphosphate, CRISPR-Associated Proteins, CRISPR-Cas Systems. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 65 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prokaryotes have evolved diverse defense strategies against viral infection, including foreign nucleic acid degradation by CRISPR-Cas systems and DNA and RNA synthesis inhibition through nucleotide pool depletion. Here, we report an antiviral mechanism of type III CRISPR-Cas–regulated adenosine triphosphate (ATP) depletion in which ATP is converted into inosine triphosphate (ITP) by CRISPR-Cas–associated adenosine deaminase (CAAD) upon activation by either cA 4 or cA 6 , followed by hydrolysis into inosine monophosphate (IMP) by Nudix hydrolase, ultimately resulting in cell growth arrest. The cryo–electron microscopy structures of CAAD in its apo and activated forms, together with biochemical evidence, revealed how cA 4 or cA 6 binds to the CRISPR-associated Rossmann fold (CARF) domain and abrogates CAAD autoinhibition, inducing substantial conformational changes that reshape the structure of CAAD and induce its deaminase activity. Our results reveal the mechanism of a CRISPR-Cas–regulated ATP depletion antiviral strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenosine DeaminaseAdenosine TriphosphateCRISPR-Associated ProteinsCRISPR-Cas SystemsVerrucomicrobiaCryoelectron MicroscopyHydrolysisPyrophosphatasesSignal Transduction

Substanzen

Adenosine DeaminaseAdenosine TriphosphateCRISPR-Associated ProteinsPyrophosphatases

Autor:innen und Institutionen

  • Department of Pharmacology, School of Pharmacy, China Pharmaceutical University, Nanjing, China.
  • State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, China.
  • Chongqing Innovation Institute of China Pharmaceutical University, Chongqing, China.
  • Department of Biochemistry, School of Life Science and Technology, China Pharmaceutical University, Nanjing, China.
  • School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
  • College of Food Science and Engineering, Nanjing University of Finance and Economics, Nanjing, China.

ORCID-Profile: Yutao Li, Zhaoxing Li, Purui Yan, Chenyang Hua, Jianping Kong, Shunxiang Li, Shunli Ji, Yijun Chen, Yucheng Zhao, Peng Yang, Chunyi Hu, Meiling Lu, Meirong Chen, Yibei Xiao

Zitieren

APA

Li, Y., Li, Z., Yan, P., Hua, C., Kong, J., Wu, W., Cui, Y., Duan, Y., Li, S., Li, G., Ji, S., Chen, Y., Zhao, Y., Yang, P., Hu, C., Lu, M., Chen, M., & Xiao, Y. (2025). Antiviral signaling of a type III CRISPR-associated deaminase. Science. https://doi.org/10.1126/science.adr0393

Vancouver

Li Y, Li Z, Yan P, Hua C, Kong J, Wu W, et al. Antiviral signaling of a type III CRISPR-associated deaminase. Science. 2025. doi:10.1126/science.adr0393

BibTeX
@article{Li2025,
  author = {Li, Yutao and Li, Zhaoxing and Yan, Purui and Hua, Chenyang and Kong, Jianping and Wu, Wanqian and Cui, Yurong and Duan, Yan and Li, Shunxiang and Li, Guanglei and Ji, Shunli and Chen, Yijun and Zhao, Yucheng and Yang, Peng and Hu, Chunyi and Lu, Meiling and Chen, Meirong and Xiao, Yibei},
  title = {Antiviral signaling of a type III CRISPR-associated deaminase},
  journal = {Science},
  year = {2025},
  doi = {10.1126/science.adr0393}
}
Kostenlos starten →